FREQUENCY OF LEUKOPLAKIA OF THE BLADDER AND THE ROLE OF SURGICAL TREATMENT : AN ANALYSIS OF A SIX-YEAR PERIOD
Abstract
Bladder leukoplakia, or squamous keratinizing metaplasia (SKM), is a rare disease in which the normal transitional epithelium is transformed into a squamous epithelium over which there is a layer of keratin. In most patients, typical non-specific symptoms of the lower urinary tract are expressed. Worldwide the representation of leukoplakia of the bladder is 1:10 000 cases. Surgical treatment is currently the gold standard in leukoplakia therapy. The goals of the study are to determine the prevalence of bladder leukoplakia, as well as the impact of surgical treatment of leukoplakia on the improvement of lower urinary tract symptoms. We analyze a series of 2,665 patients diagnosed with cystitis, out of a total of 70,620 patients from the entire territory of the Republic of N. Macedonia, who were examined and treated in the urology department at the GOB "8th of September " - Skopje, for the period from 01.01.2018 to 01.06.2024. Out of 70 620 patients, 2665 patients (3.77%) were diagnosed with cystitis, of which 1768 (66.4%) were female. The IPSS (international prostate symptom score) questionnaire showed a postoperative improvement of 65.4%. Leukoplakia of the bladder is a rare urological disease, which is exclusive to the female sex. the postoperative result of the IPSS score questionnaire showed a significant improvement in symptoms.
Keywords: bladder leukoplakia, lower urinary tract symptoms, IPSS score
References
2. Hussain SA, Alhalabi F, Zimmern PE. Long-term efficacy of fulguration of trigonitis for recurrent urinary tract infections in women. Urol Sci. 2015;26:197-201.
3. A1 S, Schlechte H, Sachs M, Kristiansen G, Burkhardt M, Schnorr D. Clinical value of vesical leukoplakia and evaluation of the neoplastic risk by mutation analyses of the tumor suppressor gene TP53. Int J Urol. 2006;13:1092-1097.
4. Lee KS, Yoo TK, Liao L, et al. Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study. BMC Urol. 2017;17:108.
5. Benelli A, Varca V, Vaccaro C, et al. Keratinizing squamous metaplasia of the bladder: our experience and current approaches. Urologia. 2018;3:391560318810197.
6. Ablove T, Bell LN, Liang H, Chappell RJ, Toklu HZ, Yale SH. The effect of solifenacin on postvoid dribbling in women: results of a randomized, double-blind placebo-controlled trial. Int Urogynecol J. 2018;29:1051-1060.
7. McKenney JK. Precursor lesions of the urinary bladder. Histopathology. 2019;74:68-76.
8. Khan MS, Thornhill JA, Gaffney E, Loftus B, Butler MR. Keratinising squamous metaplasia of the bladder: natural history and rationalization of management based on review of 54 years experience. Eur Urol. 2002;42:469-474.
9. Steven PP, Pinkstaff DM, Kevin JW, Kenneth JB. Leukoplakia of the bladder. Infect Urol. 2003;16:95-102.
10. Costantini E, Zucchi A, Del Zingaro M, Mearini L. Treatment of urethral syndrome: a prospective randomized study with Nd:YAG laser. Urol Int. 2006;76:134-138.
11. Grzech-Lesniak K, Sculean A, Gaspirc B. Laser reduction of specific microorganisms in the periodontal pocket using Er:YAG and Nd:YAG lasers: a randomized controlled clinical study. Lasers Med Sci. 2018;33:1461-1470.
12. Rofeim O, Hom D, Freid RM, Moldwin RM. Use of the neodymium:YAG laser for interstitial cystitis: a prospective study. J Urol. 2001;166:134-136.
13. Connery DB. Leukoplakia of the urinary bladder and its association with carcinoma. J Urol. 1953;69:121-127. doi:10.1016/S0022-5347(17)68038-8.